A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China
The incidence of hepatocellular carcinoma (HCC) in southern China, including Guangxi Province, is among the highest in the world. Investigations of the etiology of HCC in this area have focused on hepatitis B virus (HBV) and aflatoxin. However, hepatitis C virus (HCV) has been shown to be a possible...
Saved in:
Published in: | Cancer Vol. 73; no. 1; p. 58 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
01-01-1994
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The incidence of hepatocellular carcinoma (HCC) in southern China, including Guangxi Province, is among the highest in the world. Investigations of the etiology of HCC in this area have focused on hepatitis B virus (HBV) and aflatoxin. However, hepatitis C virus (HCV) has been shown to be a possible pathogenic agent for HCC in a number of countries.
Antibodies to HCV (anti-HCV), determined by second-generation enzyme immunoassay, and hepatitis B surface antigen (HBsAg) were assayed in the sera of 186 patients with HCC and 48 healthy control subjects from Guangxi Province in southern China.
HBsAg was detected in 131 (70.4%) of 186 patients with HCC, whereas only 10 (5.4%) patients were found to be positive for anti-HCV. The prevalence of anti-HCV in patients with HBsAg-positive HCC was 6.9% (9 of 131) and that in patients with HBsAg-negative HCC was 1.8% (1 of 55); there was no significant difference between these two groups. Anti-HCV was not detected in any of the healthy control subjects, in whom the prevalence of HBsAg was 10.4% (5 of 48).
These findings indicate that HCV does not seem to play an important role in the development of HCC in Guangxi Province; however, HBV infection appears to be a major pathogenic factor for HCC in this area. |
---|---|
AbstractList | The incidence of hepatocellular carcinoma (HCC) in southern China, including Guangxi Province, is among the highest in the world. Investigations of the etiology of HCC in this area have focused on hepatitis B virus (HBV) and aflatoxin. However, hepatitis C virus (HCV) has been shown to be a possible pathogenic agent for HCC in a number of countries.
Antibodies to HCV (anti-HCV), determined by second-generation enzyme immunoassay, and hepatitis B surface antigen (HBsAg) were assayed in the sera of 186 patients with HCC and 48 healthy control subjects from Guangxi Province in southern China.
HBsAg was detected in 131 (70.4%) of 186 patients with HCC, whereas only 10 (5.4%) patients were found to be positive for anti-HCV. The prevalence of anti-HCV in patients with HBsAg-positive HCC was 6.9% (9 of 131) and that in patients with HBsAg-negative HCC was 1.8% (1 of 55); there was no significant difference between these two groups. Anti-HCV was not detected in any of the healthy control subjects, in whom the prevalence of HBsAg was 10.4% (5 of 48).
These findings indicate that HCV does not seem to play an important role in the development of HCC in Guangxi Province; however, HBV infection appears to be a major pathogenic factor for HCC in this area. |
Author | Inoue, K Lu, B Y Okuno, H Takasu, M Kano, H Shiozaki, Y Qin, X Xie, Z C |
Author_xml | – sequence: 1 givenname: H surname: Okuno fullname: Okuno, H organization: Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan – sequence: 2 givenname: Z C surname: Xie fullname: Xie, Z C – sequence: 3 givenname: B Y surname: Lu fullname: Lu, B Y – sequence: 4 givenname: X surname: Qin fullname: Qin, X – sequence: 5 givenname: M surname: Takasu fullname: Takasu, M – sequence: 6 givenname: H surname: Kano fullname: Kano, H – sequence: 7 givenname: Y surname: Shiozaki fullname: Shiozaki, Y – sequence: 8 givenname: K surname: Inoue fullname: Inoue, K |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7506119$$D View this record in MEDLINE/PubMed |
BookMark | eNotUEtLAzEYzKFS2-pPEHJUMDX5sq9UEZa11kKxIgreSjabdSPbZNlHa4_-c1vtaZgHMzBD1LPOaoRiRseMUrhhVISEMg8umRAeZZRdhXzC7vxoMonnDyR5Tl4hAhpyyhjc8zEdJ8tbINMeGlBKI-J7_OMUDZvma09D8Hkf9UOfBoyJAfqJcem2uKr1RpbaKo1djqVtDSl0JVvTmgYneGPqrvmTU5ftsLH44GnbNnhr2gL_ZZ3SZdmVssZK1spYt5aH5KyT9vPb4Jfabcx-4Bo3rmsLXVucFMbKM3SSy7LR50ccoffH6VvyRBbL2TyJF0R5HgMS-EEYguY5iFxJmUImRerzNNUi01wCRJn2lUcjBizPheJcgQqAQSbSPNQRjNDFf2_VpWudrararGW9Wx2vgF-442xN |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/1097-0142(19940101)73:1<58::AID-CNCR2820730112>3.0.CO;2-E |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 7506119 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- -~X .GA .GJ 05W 0R~ 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52T 52U 52V 52W 52X 53G 5GY 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 85S 8UM AAESR AAHHS AAONW AARRQ AAWTL ABCQN ABEML ABHFT ABIVO ABJNI ABLJU ABOCM ABPPZ ACGFO ACGFS ACNCT ACPRK ACSCC ACXQS ADBBV ADKYN ADOZA ADZMN ADZOD AENEX AEUQT AFBPY AFRAH AGNAY AI. AIAGR ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR ATUGU AZBYB BAFTC BAWUL BY8 C45 CGR CS3 CUY CVF D-6 D-7 D-E D-F DIK DR2 DRFUL DRMAN E3Z EBS ECM EIF EJD F04 F5P FD6 GNP GODZA GX1 H.X HBH HHY HHZ HZ~ IH2 IX1 J0M J5H JPC KQQ KZ1 L7B LATKE LC2 LC3 LITHE LOXES LSO LUTES LW6 MK4 MRFUL MRMAN MSFUL MSSTM N04 N05 N4W N9A NEJ NF~ NNB NPM O66 O9- OHT OIG OK1 OVD P2P P2W P2X P2Z P4B Q.N QRW RWI RX1 SJN SUPJJ TEORI UDS UHB V8K V9Y VH1 W8V W99 WBKPD WH7 WIH WIJ WIK WIN WJL WVDHM WXI XV2 Y6R Z0Y ZGI ZXP ~WT |
ID | FETCH-LOGICAL-c4412-656772e3f29fcaab2da9b53bbe9de3a228de5c408121ff9c33c2c6212d9bf7e82 |
ISSN | 0008-543X |
IngestDate | Sat Sep 28 08:34:21 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4412-656772e3f29fcaab2da9b53bbe9de3a228de5c408121ff9c33c2c6212d9bf7e82 |
PMID | 7506119 |
ParticipantIDs | pubmed_primary_7506119 |
PublicationCentury | 1900 |
PublicationDate | 1994-Jan-01 |
PublicationDateYYYYMMDD | 1994-01-01 |
PublicationDate_xml | – month: 01 year: 1994 text: 1994-Jan-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Cancer |
PublicationTitleAlternate | Cancer |
PublicationYear | 1994 |
SSID | ssj0007253 |
Score | 1.5925617 |
Snippet | The incidence of hepatocellular carcinoma (HCC) in southern China, including Guangxi Province, is among the highest in the world. Investigations of the... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 58 |
SubjectTerms | Adult Aged alpha-Fetoproteins - analysis Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - microbiology China Female Hepacivirus - immunology Hepatitis Antibodies - blood Hepatitis B Surface Antigens - blood Humans Liver Neoplasms - blood Liver Neoplasms - microbiology Male Middle Aged Prevalence |
Title | A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7506119 |
Volume | 73 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdaENNeEF8TjA_5gUqg4m2xnSYpCClkQSCxTcCQ-jYljg3RmDPRdfDKf875I0m7CQQPSFUU2VYc-369nM--3yH0GL5BRaSCgkS0KglXSUWSiHIyETJmKthRUGRcFx-j_Vm8m_N8MGjzuPZl_1XSUAayNpGz_yDt7qFQAPcgc7iC1OH6V3JPx1-b7yb0Hx5q_7Vmo1-f1eSLNIenz-r5OBuf198Wc1tcNpWN_PP8qj7YzbZtjFPfnlIVJuGQbk4K0xJApT__qE2IwXmtnQ9-3tiD8rpPx73EfiD6A8AHxwub6rsPiZj5_ZHeW_tuYTE37mzs947mYNY7KBzTcOegaJVuTELOZstK1-UvWQGX06COyP2SYndEsWa7HJ7NqSGxgq4MQd7IZN8yxBMjloUx3MAvfbtLsv3sA6wnnQqjI5azrZ2t7GDEXlGSL_cB7U9PLBrAepoEToP_sfICQ7evGaIhmFvGIs_2OmMgop4I1c_BGkr9cLa7wTxph_I0YtPgRRhPp5cH8NK9_nN4-XV0zXd5YS1kbaLDG-i6X8zg1KHwJhpIfQut7fnjGrfRzxQDGHEPRtwovApGnGELRtyCEdcat2DEBox4FYy4A6Np6cGIWzA-wy0UsYXiHfTpdX6YvSE-5wcRYJhTAssLWO9JpmiiRFGUtCqSMmRlKZNKsoLSuJKh4GDI0kCpRDAmqJiA_VUlpYpkTDfQFd1oeRdhVioViBhs7knIC0ObJrkIBQsTWHJEgt9DG27yjk4dscuRn9XN31XcR-s9wB-gqwp0hnyIhvNq8ciK_RdcCn_w |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+low+prevalence+of+anti-hepatitis+C+virus+antibody+in+patients+with+hepatocellular+carcinoma+in+Guangxi+Province%2C+southern+China&rft.jtitle=Cancer&rft.au=Okuno%2C+H&rft.au=Xie%2C+Z+C&rft.au=Lu%2C+B+Y&rft.au=Qin%2C+X&rft.date=1994-01-01&rft.issn=0008-543X&rft.volume=73&rft.issue=1&rft.spage=58&rft_id=info:doi/10.1002%2F1097-0142%2819940101%2973%3A1%3C58%3A%3AAID-CNCR2820730112%3E3.0.CO%3B2-E&rft_id=info%3Apmid%2F7506119&rft_id=info%3Apmid%2F7506119&rft.externalDocID=7506119 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |